🇬🇧 Antibiotic-resistant sepsis still claiming newborn lives in Africa: Penta leads new scientific collaboration to improve treatment and reduce mortality

27 Jul, 2023

Padova (Italy), 27 July 2023 – A new European-African collaboration to improve the way infections in newborns are treated is launching today. The project, called SNIP-AFRICA, aims to reduce mortality…

🇬🇧 Penta unveils Brighter Future Award 2023: Recognising innovators and visionaries driving positive change

15 Jun, 2023

Padua, Italy, 15 June 2023 – Penta, an international independent scientific network dedicated to maternal and child health research, is proud to unveil the Brighter Future Award (BFA), an annual…

🇬🇧 Global study highlights deaths from neonatal sepsis and steps to improve treatment

08 Jun, 2023

Geneva, 8 June 2023 – A global observational study, which involved more than 3,200 newborn babies suffering from sepsis in 19 hospitals in 11 countries, has shown that many newborns…

🇮🇹 Sepsi nei neonati: ancora alta la mortalità nel mondo. Nuovi strumenti per facilitare diagnosi e cura

08 Jun, 2023

Studio internazionale condotto da Global Antibiotic Research and Development Partnership (GARDP) e Penta – Child Health Research. Coinvolti 19 ospedali di 11 Paesi, l’Ospedale Pediatrico Bambino Gesù per l’Europa. La…

🇮🇹 Nuovo finanziamento dall’Unione Europa all’Università di Padova e Penta per la ricerca su mpox e nuove epidemie

03 Apr, 2023

Il Consorzio VERDI, coordinato dal Dipartimento di Salute della Donna e del Bambino (SDB) dell’Università di Padova e dalla Fondazione Penta ETS, ha ricevuto dall’Unione Europea un importante finanziamento di 5…

🇬🇧 EU tasks VERDI Consortium with investigating mpox and improving pandemic preparedness

30 Mar, 2023

The VERDI Consortium, coordinated by the University of Padua and Fondazione Penta ETS (Italy), has received an additional €5 million funding from the European Union (EU). Thanks to this contribution,…

🇬🇧 Experts call for urgent action to develop antibiotics for newborns

07 Dec, 2022

Padua (Italy), 7 December 2022 – Leading public health experts from around the globe are calling for urgent action to develop antibiotics for newborn babies, a population that is particularly…

🇮🇹 Il vaccino Pfizer-BioNTech BNT162b2 (Comirnaty) offre una protezione moderata dalla variante Omicron nei bambini dai 5 agli 11 anni

30 Jun, 2022

Padova, 30 giugno 2022 Il vaccino Pfizer-BioNTech BNT162b2 (Comirnaty) offre una protezione moderata dalla variante Omicron nei bambini dai 5 agli 11 anni. Lo dimostra un ampio studio appena pubblicato…

🇬🇧 Study reveals moderate effectiveness of Pfizer Covid-19 vaccine against Omicron in children aged 5-11

30 Jun, 2022

Padua, 30 June 2022 – A large study on the effectiveness of the Pfizer Covid-19 vaccine in children aged 5-11 was published in The New England Journal of Medicine. The study…

🇬🇧 GARDP study reveals that babies are increasingly dying of neonatal sepsis caused by drug-resistant bacterial infections

26 Apr, 2022

Geneva, 26 April 2022 – A large study focusing on newborn babies with clinically diagnosed sepsis has revealed the impact of antibiotic resistance on neonatal sepsis, a major cause of…

🇮🇹 Uno studio di GARDP rivela che i neonati muoiono sempre più frequentemente per sepsi neonatale causata da infezioni batteriche resistenti ai farmaci

26 Apr, 2022

Ginevra, 26 Aprile 2022 – Un importante studio sui neonati ha rivelato l’impatto della resistenza agli antibiotici sulla sepsi neonatale, una delle principali cause di morte tra i neonati. Al…

🇬🇧 European RBDCOV project to study HIPRA’s COVID-19 vaccine in children adolescents and immunocompromised patients

15 Feb, 2022

Funded by the Horizon Europe programme, RBDCOV will test the efficacy, tolerability, and safety of the vaccine against the different variants of COVID-19 using a recombinant protein. …

🇬🇧 Easy-to-take medicine better at suppressing HIV in children

30 Dec, 2021

UCL press release A once-a-day antiretroviral medicine that is low-cost and easy for children to take is also more effective at suppressing HIV than standard treatments, according to a global…

🇬🇧 NeoVanc: New study finds no clear benefit from a shorter optimised vancomycin treatment in babies with Gram positive late onset sepsis

27 Nov, 2021

The results of the study show that there is no clear advantage for adopting a shorter 5-day course, with a loading dose, over the standard 10-day course in infants under…

🇬🇧 VERDI project launches

15 Nov, 2021

Today we launch VERDI, a project that prioritizes women and children in the research on new coronavirus variants The University of Padua and Penta Foundation are leaders of VERDI, a new European research…

🇬🇧 New data on the duration of immune protection against SARS-CoV- 2 in children

02 Jul, 2021

A study published in the Pediatrics journal shows that children with mild forms of COVID-19 develop a greater and longer lasting antibody response than that of adults. The study involved 57…

🇮🇹 Nuovi dati sulla durata della protezione immunitaria contro SARS-CoV-2 nei bambini

28 Jun, 2021

Università degli Studi di Padova, Istituto Zooprofilattico Sperimentale delle Venezie e Penta presentano nuovi dati sulla durata della protezione immunitaria contro SARS-CoV-2 nei bambini Uno studio pubblicato in questi giorni…

🇮🇹 NeoIPC: strategie di prevenzione e di controllo delle infezioni neonatali

15 Jun, 2021

Parte da Padova il progetto europeo NeoIPC, che mira a ridurre le infezioni e la trasmissione di batteri resistenti nelle unità di terapia intensiva neonatale. Padova, 15 giugno 2021 –…

🇬🇧 NeoIPC: a new project to improve prevention and control of infections in newborns

19 May, 2021

NeoIPC, a project seeking to reduce the transmission of resistant bacteria in neonatal intensive care units, has just launched.

🇮🇹 CORONA: bambini e COVID-19

21 Apr, 2021

Un progetto a guida italiana sostenuto da UniCredit Foundation Padova, 21 Aprile 2021 – Parte il progetto CORONA: bambini e COVID-19, sostenuto da UniCredit Foundation e condotto dalla Fondazione Penta di…

🇬🇧 CORONA: children and COVID-19

21 Apr, 2021

An Italian-led project supported by the UniCredit Foundation to study the impact of the coronavirus on children.

🇬🇧 New European-African collaboration to develop UNIVERSAL treatments for children living with HIV

03 Feb, 2021

Today marks the official launch of UNIVERSAL, the newly funded European-African clinical research partnership that aims to develop two antiretroviral formulations for children living with HIV and to speed up…

🇬🇧 PREPARE activated to Mode 2 in response to novel Coronavirus cases in Europe

06 Feb, 2020

On 30th January 2020, the Director General of the World Health Organisation (WHO) declared the outbreak of 2019-nCoV a public health emergency of international concern. In his statement, Dr Tedros…

🇬🇧 GARDP and Penta partner to accelerate the development of children’s antibiotics to tackle AMR

01 Apr, 2019

Geneva / Padova, Monday 4 March 2019 – The Global Antibiotic Research & Development Partnership (GARDP) and Penta, the paediatric infectious diseases research network, have joined forces to tackle drug-resistant…

🇬🇧 University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics